Results 11 to 20 of about 3,441 (189)

Acute midodrine overdose: a case report [PDF]

open access: yesToxicology Communications, 2021
Midodrine is a prodrug metabolized to the peripheral acting alpha agonist desglymidodrine and is used to treat orthostatic hypotension. Reports of overdose are rare, consequently there is little guidance regarding treatment of overdose.
Jessica Peck, Steven D. Salhanick
doaj   +2 more sources

Impact of Adjuvant Use of Midodrine to Intravenous Vasopressors: A Systematic Review and Meta-Analysis [PDF]

open access: yesCritical Care Research and Practice, 2021
Purpose. To evaluate the efficacy and safety of midodrine use in intensive care units (ICU) to facilitate weaning off intravenous vasopressors (IVV). Methods.
Ahmad Al-Abdouh   +9 more
doaj   +2 more sources

Use of oral midodrine for weaning off norepinephrine in patients with septic shock [PDF]

open access: yesEgyptian Journal of Critical Care Medicine
Background Early administration of norepinephrine in septic shock patients is linked to better survival rates. However, vasopressor dependence often occurs during the recovery phase, delaying ICU discharge. Objectives A comparative study was conducted on
Mohamed Obaya   +3 more
doaj   +2 more sources

Use of Midodrine for Intraoperative Hemostasis in Cutaneous and Percutaneous Surgery [PDF]

open access: yesJID Innovations
Owing to the increasingly high volume of cutaneous and percutaneous procedures performed annually, the demand for local anesthesia has steadily risen. The gold-standard formulations for local anesthesia contain epinephrine at a concentration of 1:100,000
Joanna Dong   +8 more
doaj   +4 more sources

The Use of Midodrine as an Adjunctive Therapy to Liberate Patients from Intravenous Vasopressors: A Systematic Review and Meta-analysis of Randomized Controlled Studies [PDF]

open access: yesCardiology and Therapy, 2023
Background Studies evaluating the role of midodrine as an adjunctive therapy to liberate patients with shock from intravenous (IV) vasopressors have yielded mixed results.
Mohamed Hamed   +9 more
doaj   +2 more sources

Oral Midodrine Administration During the First 24 Hours of Sepsis to Reduce the Need of Vasoactive Agents: Placebo-Controlled Feasibility Clinical Trial [PDF]

open access: yesCritical Care Explorations, 2021
Objectives:. Our preliminary data and observational studies suggested an increasing “off label” use of oral midodrine as a vasopressor sparing agent in various groups of critically ill patients, including those with sepsis.
Amos Lal, MBBS, FACP   +7 more
doaj   +2 more sources

Midodrine for the early liberation from vasopressor support in the ICU (LIBERATE): a feasibility study [PDF]

open access: yesPilot and Feasibility Studies
Background Intravenous (IV) vasopressors are the mainstay of physiological support for hemodynamically unstable patients. However, the role of oral vasopressors remains unclear.
Sebastian J. Kilcommons   +15 more
doaj   +2 more sources

Use of Midodrine in Heart Failure: Two Case Reports and a Review of the Literature [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2022
Hypotension in patients with heart failure is much more frequent in daily clinical practice than the 10–15% reported in clinical trials. In patients with heart failure with reduced ejection fraction (HFrEF), hypotension frequently limits the initiation ...
Adnan Hajjiah   +6 more
doaj   +3 more sources

Fludrocortisone Is Associated With a Higher Risk of All‐Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension [PDF]

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundOrthostatic hypotension causes ≈80 000 hospitalizations per year in the United States. Treatments for orthostatic hypotension include fludrocortisone, a mineralocorticoid analog that promotes sodium reabsorption; and midodrine, an α‐1 ...
Carlos G. Grijalva   +3 more
doaj   +2 more sources

Systemic reviews and meta-analysis of the use of midodrine in hepatorenal syndrome [PDF]

open access: yesRomanian Medical Journal
Aims. This study analyzes the effectiveness of midodrine in reducing or managing Hepatorenal Syndrome (HRS). Design. A systematic review and meta-analysis were conducted to gather and assess relevant literature. The review included evaluating study aims,
Prem Balaji Reddy Lankapothu   +3 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy